Adcock invests $40M in Johannesburg facility; Accellent selling plant to Perryman;

> Thirty-three cases of a rare fungal eye infection have been traced to Franck's Compounding Lab in Ocala, FL, where tests of products by the FDA found drugs contaminated by a variety of fungi and bacteria. Story

> Adcock Ingram of South Africa has opened a $38.3 million manufacturing facility in Johannesburg to make sterile drip bags, ampules and dialysis solutions for the sub-Saharan Africa market. Item

> Accellent, a contract manufacturer for the medical device industry, has agreed to sell a 68,000-square-foot manufacturing facility in Houston, PA, near Pittsburgh, to titanium producer The Perryman Company for an undisclosed sum. Release

> FDA orders Alexza Pharmaceuticals ($ALXA) to fix manufacturing issues, which the company says are device-related, before it will approve its NDA for Adasuve, a schizophrenic and bipolar disorder treatment. Story

 

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.